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Reportamos neste trabalho o estudo sistemático de fragmentação dos derivados de N-óxidos de
1,2,5-oxadiazóis por espectroscopia de massa, usando análogos marcados com deutério para identificar
algumas fragmentações críticas. Foi confirmada a perda neutra de CH2O a partir do N2-óxido de 3-
hidroximetil-4-fenil-1,2,5-oxidiazol, usando o análogo mono-deuterado. A perda de OH, a partir do
oxigênio do N-óxido, por um rearranjo β-H e δ-H, foi claramente verificada a partir do N2-óxido de
3-(4-metilpiperazina-1-metil)-4-fenil-1,2,5-oxidiazol, usando-se o analogo tetra-deuterado adequado.
O isômero N-óxido e análogos desoxigenados foram também usados para confirmar a participação
do fragmento óxido no processo de defragmentação.
This paper reported on the study of fragmentation pattern in mass spectrometry of 1,2,5-oxadiazole
N-oxide derivatives involving deuterium-labeled analogues to identify some critical fragmentations.
A neutral CH2O loss from 3-hydroxymethyl-N2-oxide-4-phenyl-1,2,5-oxadiazole was confirmed
with the corresponding mono-deuterated analogue. An OH loss, involving the oxygen of N-oxide,
via β-H and δ-H rearrangement, was clearly revealed from 3-(4-methylpiperazine-1-ylmethyl)-N2-
oxide-4-phenyl-1,2,5-oxadiazole using the adequate tetra-deuterated analogue. N-oxide isomer and
deoxygenated analogues were also used to confirm the participation of the oxide moiety in the
fragmentation process.
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Introduction
As part of an ongoing research program on the chemistry
and biological characterization of N-oxide containing
molecules, a number of 1,2,5-oxadiazole N-oxide,
benzo[1,2-c]1,2,5-oxadiazole N-oxide, quinoxaline N,N’-
dioxide, and 1,2,4-triazine N-oxide derivatives were
synthesized and evaluated against different biological
targets.1 In the course of our synthetic chemical approach
we developed 1,2,5-oxadiazole N-oxide derivatives as
potential herbicides,2 bioreductive compounds,3-6 and anti-
trypanosomal drugs,7,8 using previously described
synthetic methods.9 During the structural elucidation of
these derivatives, we were interested in knowing about
the presence and the exact location of the N-oxide
functionality. Simple and readily available spectroscopic
techniques (e.g. IR and 1H NMR) are not able to
unambiguously characterize the presence of an N-oxide
group. For example, the characteristic IR absorptions of
=N+-O– (1300-1200 cm-1 and 970-950 cm-1) are not
considered a conclusive proof because these bands can
overlap with the fingerprint bands.10 Similarly, 1H NMR
spectroscopy can not afford important information about
the =N+-O– system, because these products are heterocycles
devoid of protons. However, more recently 2D-HETCOR
experiments (sequences of HMQC for one-bond correlation
and sequences of HMBC for long distance/carbon
correlation) provide us very important data about the
presence and position of the =N+-O– moiety.
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In this context, the initial aim of the present study was
to characterize the fragmentation pattern in mass
spectrometry of the 1,2,5-oxadiazole N-oxide derivatives
as an alternative structural determination technique. On
the other hand, this work describes the elucidation of the
fragmentation patterns of these compounds through the
use of deuterated derivatives,11 N-oxide isomer and
deoxygenated (without N-oxide) analogues.12
Results and Discussion
The spectra for selected derivatives 1-13 (Figure 1)
revealed different fragmentation patterns, resulting from
different side chains of the 1,2,5-oxadiazole heterocycle
at C-3. The most relevant mass spectral data for derivatives
1-13 are presented in Table 1 and Figure 2 rationalizes
important fragmentation pathways.
The molecular ion was detected in all cases. However,
the abundances were very low for derivatives 4-6, which
contain a residue proven to undergo retro-Diels-Alder-
fragmentation (morpholine, thiomorpholine, and
methylpiperazine).13 The same was observed for derivative
12, that bears an aliphatic side chain on the semicarbazone
moiety. The [M-16u]+• ion, corresponding to an oxygen
loss, was observed in all cases as a relatively small peak.
However, the peak corresponding to m/z [M-17u]+, became
increasingly important for derivatives 4-7 and 11 as result
of an OH• loss. This kind of fragmentation has been
previously described for similar moieties, e.g., a NO2 group
losses OH• in o-nitrotoluenes and o-nitroanilines,13 or for
other adequately substituted N-oxide heterocycles.14,15 In
these compounds, two different rearrangement processes
could explain this radical loss, β-H and/or δ-H rearrangement
(Figure 3). The high abundance of this fragment ion for
derivatives 4-7 (non-aromatic cyclic amine derivatives)
compared to fragment ion abundance’s for derivatives 8-10
(phenylamino derivatives) made us to think that a δ-H
rearrangement was the main process in this kind of structures.
With a conventional EI/MS equipment it is not possible to
study this fact and others, e.g., to determine whether the
[M-30u]+ fragment ion in derivative 1 corresponds to a NO
loss (as for the other derivatives) or a CH2O loss from the
hydroxymethyl substituent in 3-position of the 1,2,5-
oxadiazole heterocycle is due to an initial γ-H transference,
which produces the stable neutral-product formaldehyde
(Figure 4).
In order to explain these critical fragmentations in mass
spectrometry, using a EI/MS equipment, we centered our
Table 1. Abundance of the most characteristic fragment ions in the
corresponding 1,2,5-oxadiazole N-oxide derivatives EI mass spec-
trum
Compound Abundance (%) a,b
No M+• M+•-16 M+•-17 M+•-30 M+•-60 M+•-61
1 15.7 0.5 0.2 20.7 58.0 100.0
2 27.6 0.5 0.2 25.5 62.5 100.0
3 12.0 0.3 0.3 10.6 35.3 1.7
4 0.8 0.9 4.1 0.2 0.3 0.7
5 0.8 1.9 11.8 1.3 0.2 0.3
6 0.3 8.5 50.4 0.2 1.0 0.8
7 10.0 7.1 33.8 0.6 0.2 0.3
8 10.6 1.1 0.1 - c 1.1 2.6
9 12.1 2.1 - - 1.1 2.5
10 21.2 3.9 1.7 - 1.6 1.6
11 10.6 3.5 11.3 57.6 55.5 6.8
12 0.2 0.2 0.8 31.8 7.3 0.3
13 2.3 - - 7.5 13.3 -
a Analytical conditions for EI/MS: direct injection, ion source tem-
perature 250 ºC, energy 70 eV. b The results are the averages for
three independent experiments. c The “-” denotes that the fragment
ion was not observed.
Figure 1. Series of 1,2,5-oxadiazole N-oxide developed in order to study their biological activity.
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efforts on the synthesis of deuterium analogues of some
selected furoxan derivatives.16,17 Initially, we tried to
prepare di-deuterium analogue, at the benzylic position,
of derivative 6. The synthesis of the di-deuterium chloride
3 was attempted by trying to exchange the “acidic”
benzylic-protons using a biphasic system NaOD-D2O/
CDCl3 at different temperatures (room temperature to reflux
for 24 h) (as shown in Scheme 1). Unfortunately, 1 H-NMR
monitoring of the reaction mixture showed no significant
exchange under these conditions. When CD3O-Na+ /
CD3OD was used, exchange took place, but the ether 14
was obtained as the result of the substitution by the
powerful nucleophile deuterated methoxide (Scheme 1).
These synthetic problems led us to undertake the
preparation of the mono-deuterium analogue of derivative
6, at the benzylic position, with 3-d1 as starting material
(Scheme 1). Using the aldehyde 2, the mono-deuterium
alcohol 1-d1 was produced with more than 95% of
Figure 2. Most characteristic fragment ions in the 1,2,5-oxadiazole N-oxide derivatives EI mass spectrum.
Figure 3. Postulated mechanism for the OH• loss in compounds 4, 5, 6 and 7 (Note: we are gratefully thank to one of the referee for suggesting
the structure of the final product of the δ-H rearrangement).
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deuterium incorporation verified by 1H-NMR analysis,
employing the deuterated-metal reductor-NaBD4 (Scheme
1). The N-oxide moiety was maintained in position N2
during the reaction of derivative 2 with sodium
borodeuteride. This fact was observed through the
corresponding 2D-NMR experiments, which showed a
quaternary carbon (HMQC experiment) at 115.36 ppm
correlating with a proton at 4.73 ppm (HMBC experiment)
and another quaternary carbon (HMQC experiment) at
157.31 ppm correlating with protons at 4.73 ppm and 7.84
ppm (HMBC experiment). These HETCOR experiments
allowed us to assign unambiguously the heterocyclic
carbon atoms (dC-3 = 115.36 ppm, dC-4= 157.31 ppm) (Figure
5). The product 1-d1 was then transformed in a good yield
into the corresponding chloride 3-d1 using thionyl chloride
(Scheme 1).
Finally, the amine derivative 6-d1 was obtained by the
reaction between chloride 3-d1 and N-methylpiperazine
(Scheme 2). The molecular structure of derivative 6-d1 has
been determined by X-ray diffraction methods (Figure
6).18,19 In addition, we prepared 6-d4, the tetra-deuterium
analogue in the 2,6-position of piperazine ring, through
reaction between the chloride 3 and the heterocyclic amine
Figure 4. Postulated mechanism for the NO• and CH2O loss in compounds 1.
Figure 5. HMBC correlation for derivative 1-d1.
Scheme 1.
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17 (Scheme 2). This amine was deuterated via the
nitrosamine 15, prepared following the Ravindran et al.
procedure,20 which was converted into the tetra-deuterium
analogue 16 following the Keefer-Fodor methodology.21
To transform nitrosamine 16 into amine 17 we tried a
procedure by Kano et al. (reduction with NaBH4:TiCl4 (2:1)
in diglyme) with bad results.22 The reduction process did
not occur and probably, a complex between the
methylpiperazine nitrosamine and TiCl4 was obtained. The
use of H2 in Raney-Nickel at room temperature and
atmospheric pressure led to compound 17 in an adequate
yield.23 The deuterium incorporation in compound 16 was
more than 95% (by 1H-NMR analysis).
To know how the N-oxide group position affect on the
furoxans’ mass spectrometry behavior, we prepared the N-
oxide-positional isomer 3-i. This compound was obtained
via the alcohol 1-i, which was prepared following the Gasco
et al. methodology (Scheme 3).10 To study the
fragmentation patron of the molecule “N-oxide-free”, we
prepared the deoxygenated analogues 1-deoxy and 7-deoxy
using Zn in NH4Cl solution as the reduction reagent
(Scheme 3).6,24 These products were clearly confirmed
through HETCOR experiments (HMQC and HMBC).
Mass spectrometry was carried out on all the analogues
developed. The most characteristic peaks in the mass
spectrum (EI/MS) for derivatives 1-d1, 1-deoxy, 3-d1, 3-i,
6-d1, 6-d4 and 7-deoxy, together with those for parent
compounds 1, 3, 6 and 7, are presented in Table 2. The
results clearly indicate that the fragmentation process of
compound 1-d1 does not occur exclusively through a NO•
loss, the [M-31u]+• ion (not present in the parent compound
1) probably arise from a CDHO loss. On the other hand,
comparing the relative abundance of the M+• and [M-30u]+•
ions in compounds 1-deoxy and 7-deoxy, 9.9% and 1.6%
respectively, we could notice that the [M-30u]+• ion was
more abundant in the first one, this fact is in accordance
with the neutral CH2O loss fragmentation process in
derivative 1.
The mass spectrum of positional isomer 3-i did not
show the [M-17u]+• and [M-31u]+• ions, this fact could be
indicative that the parent compound 3 losses OH. and HNO
as a β-H participation. Deuterium labeling of compound 6
indicated that the [M-17u]+• ion of this derivative was the
result of β-H and δ-H rearrangements (see Table 2). While
derivative 6 showed an [M-17u]+• ion abundance of 50.4%,
derivatives mono- and tetra-deuterated (6-d1 and 6-d4), that
could present the β-H and the δ-H rearrangement
phenomena, showed the abundances of the corresponding
Scheme 2.
Figure 6. Molecular plot of derivative 6-d1. The ORTEP drawing of
the molecule shows the labeling of the non-H(D) atoms and their
displacement ellipsoids at 30% probability level.
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ion ([M-18u]+•) near to 20% (23.0 and 17.0%, respectively).
Unfortunately, the mono-deuterium analogue, 6-d1, did not
allow us to conclude about the kind of the initial
H-rearrangement, because the benzylic position contain
one hydrogen and one deuterium. On the other hand, the
tetra-deuterium analogue, 6-d4, permitted us to confirm
both initial rearrangement pathways, yielding two possible
stable radical cations. The high abundance of the [M-18u]+•
ion in derivative 6-d4, and the very low abundance in the
parent compound, indicated the participation of the
deuterium atom in a fragmentation process.
Further the deoxygenated derivatives 1-deoxy and
7-deoxy allowed us to establish that in the parent
compounds the loss of oxygen, as expected, principally
occurs from the N-oxide moiety. The deoxy-derivatives
showed the [M-16u]+• ion in a very low abundance, i.e.
abundance ([M-16u]+•) / abundance (M+•) = 0.002 for 1-
deoxy and 0.031 for 7-deoxy (compare with the corres-
ponding abundance ([M-16u] +•) / abundance (M+•) values
for 1 and 7, 0.032 and 0.71 respectively), probably due to
an oxygen loss from the heterocycle system 1,2,5-
oxadiazole. In the deoxy-analogues the [M-17u]+• ion
could be the result of a further H• loss.
Scheme 3.
Table 2. Abundance of the critical fragment ions in the corresponding 1,2,5-oxadiazole N-oxide analogues EI mass spectrum
Abundance (%) a,b
Compound No M+• M+• M+• - 16 M+• - 17 M+• - 18 M+• - 30 M+•- 31 M+• - 61 M+• - 62
1 192 15.7 0.5 0.2 0.6 20.7 - c 100.0 0.8
1-d1 193 25.6 1.7 0.6 1.1 27.8 3.0 100.0 20.4
1-deoxy 176 100.0 0.2 1.2 0.3 9.9 3.5 8.2 6.0
3 210 12.0 0.3 0.3 - 10.6 0.1 1.7 0.1
3-d1 211 12.2 0.2 0.3 0.1 11.4 1.2 4.7 0.3
3-i 210 8.6 0.1 - - 6.9 - 1.6 -
6 274 0.3 8.5 50.4 0.4 0.2 0.2 0.8 0.3
6-d1 275 1.2 7.7 45.6 23.0 0.3 - 0.7 0.5
6-d4 278 0.3 8.7 46.2 17.0 - - 0.4 0.1
6-d4 d 278 4.6 17.1 100.0 35.5 0.3 - 2.6 0.9
7 338 10.0 7.1 33.8 0.2 0.6 0.2 0.3 -
7-deoxy 322 12.7 0.4 1.7 0.1 0.2 0.1 0.5 1.1
a
 MS experiments were performed using a Shimadzu MS QP 1100 EX equipment, with EI at 70 eV, with direct insertion probe, the ion source
temperature 250 ºC and the mass range was 40-500 amu. b The results are the averages for three independent experiments. c The “-” denotes that
the fragment ion was not observed. d At 20 eV, ion source temperature 150 ºC. These conditions were used in order to increase the abundance
of the peak of the molecular ion, other conditions and other products were not studied.
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Experimental
All starting materials were commercially available
research-grade chemicals and used without further
purification. All solvents were dried and distilled prior to
use. All the reactions were carried out in a nitrogen
atmosphere. The typical work-up included washing with
brine and drying the organic layer with sodium sulphate.
Compounds 1-3, 1-i, 1-deoxy, 7, 7-deoxy, 15 and 16 were
prepared as previously described.4,6,9,20,21 Elemental
analyses were obtained from vacuum-dried samples (over
phosphorous pentoxide, 24 h at room temperature) and
performed on a Fisons EA 1108 CHNS-O analyzer, and
were within ± 0.4% of theoretical values. Infrared spectra
were recorded on a Perkin Elmer 1310 apparatus, using
potassium bromide tablets; the frequencies are expressed
in cm-1. 1H-NMR spectra and HETCOR experiments were
recorded on a Bruker DPX-400 (at 400 MHz and 100 MHz)
instrument, with tetramethylsilane as the internal reference;
the chemical shifts are reported in ppm. MS experiments
were performed using the Shimadzu MS QP 1100 EX
equipment, with EI at 20 or 70 eV, with direct insertion
probe, the ion source was set a 150 ºC or 250 ºC and the
mass range was 40-500 amu.
3-(1-Deuterio-1-hydroxymethyl)-N2-oxide-4-phenyl-
1,2,5-oxadiazole (1-d1). A solution of 2 (1.0 g, 5.3 mmol)
in THF (5 mL) was stirred at 0 °C. Sodium borodeuteride
(220 mg, 5.3 mmol) was then added, and the resulting
solution was stirred for 3 h at room temperature. The solvent
was removed in vacuo and the residue was dissolved in
EtOAc. After the work-up process the residue was purified
by column chromatography (SiO2, petroleum ether:EtOAc
(10 to 30%)), to yield 600 mg (59%), mp 65.0-67.0 °C; IR
ν
max
/cm-1: OH 3400, 1560, 1410, 1050, 770, 680 cm-1; 1H
NMR (deuteriochloroform): δ 2.30 (bs, 1H, OH), 4.73 (s,
1H, -CDHOH), 7.57 (m, 3H, phenyl protons), 7.84 (m, 2H,
phenyl protons); 13C NMR (HMQC and HMBC
experiments) (deuteriochloroform): δ 53.40 (-CDH), 115.36
(-C=N+-O-), 126.55 (-C-phenyl), 128.18 (-C-phenyl),
129.80 (-C-phenyl), 131.76 (-C-phenyl), 157.31 (-C=N).
Anal. Calc for C9H7DN2O3: C, 55.96; H, 3.63; N, 14.51%.
Found: C, 56.00; H, 3.92; N, 14.35%.
3-(1-Chloro-1-deuteriomethyl)-N2-oxide-4-phenyl-
1,2,5-oxadiazole (3-d1). A mixture of 1-d1 (300 mg, 1.6
mmol) and SOCl2 (0.19 mL) was stirred at room temperature
for 24 h. The reaction mixture was treated with ice, sodium
bicarbonate saturated solution (until basic pH), and
extracted three times with EtOAc (20 mL). Then of the
work-up process the residue was purified by chroma-
tography (Al2O3, petroleum ether:EtOAc (0 to 5%)) to yield
300 mg (89%), colorless oil; IR ν
max
/cm-1: 1601, 1462,
1435, 772, 696 cm-1; 1H NMR (deuteriochloroform): δ 4.57
(s, 1H, -CDHCl), 7.56 (m, 3H, phenyl protons), 7.80 (m,
2H, phenyl protons); 13C NMR (HMQC and HMBC
experiments) (deuteriochloroform): δ 32.94 (-CDH), 113.31
(-C=N+-O-), 126.20 (-C-phenyl), 127.84 (-C-phenyl),
129.81 (-C-phenyl), 131.51 (-C-phenyl), 156.40 (-C=N).
Anal. Calc for C9H6ClDN2O2: C, 51.06; H, 2.84; N, 13.24%.
Found: C, 50.69; H, 2.99; N, 13.00%.
4-(Chloromethyl)-N2-oxide-3-phenyl-1,2,5-oxadiazole
(3-i). A mixture of 1-i (150 mg, 0.8 mmol) and SOCl2 (0.1
mL) was stirred at room temperature for 24 h. The reaction
mixture was treated with ice, sodium bicarbonate saturated
solution (until basic pH), and extracted three times with
EtOAc (20 mL). Then of the work-up process the residue
was purified by chromatography (Al2O3, petroleum
ether:EtOAc (0 to 5%)) to yield 110 mg (65%), colorless
oil%; IR ν
max
/cm-1: 1595, 1450, 1415, 770, 690 cm-1; 1H
NMR (deuteriochloroform): δ 4.72 (s, 2H, -CH2Cl), 7.58
(m, 3H, phenyl protons), 7.83 (m, 2H, phenyl protons).
Anal. Calc for C9H7ClN2O2: C, 51.31; H, 3.33; N, 13.30%.
Found: C, 51.07; H, 3.05; N, 12.92%.
3-[1-Deuterio-1-(4-methylpiperazine-1-yl)methyl]-N2-
oxide-4-phenyl-1,2,5-oxadiazole (6-d1). A mixture of 3-d1
(150 mg, 0.7 mmol), N-methylpiperazine (65 mg, 0.7
mmol), K2CO3 (100 mg, 0.7 mmol), KI (10 mg, 0.07 mmol)
and THF as solvent was heated at reflux until absence of
chloride (Al2O3, 20% EtOAc in petroleum ether). The
solvent was removed in vacuum and the residue was
purified by column chromatography (Al2O3, CH2Cl2) to
yield 100 mg (51%), mp 97.5-99.5 °C; IR ν
max
/cm-1: 2926,
2797, 1595, 1574, 1456, 768, 700 cm-1; 1H NMR
(deuteriochloroform): δ 2.29 (s, 3H, CH3-N), 2.45 (m, 4H,
-CH2N), 2.58 (m, 4H, -CH2N), 3.54 (s, 1H, -CDHN), 7.52
(m, 3H, phenyl protons), 7.92 (m, 2H, phenyl protons);
13C NMR (HMQC and HMBC experiments)
(deuteriochloroform): δ 46.27 (CH3-N), 50.04 (-CDH), 53.10
(-CH2-N), 55.23 (-CH2-N), 113.04 (-C=N+-O-), 127.35
(-C-phenyl), 128.52 (-C-phenyl), 129.47 (-C-phenyl),
131.45 (-C-phenyl), 158.00 (-C=N). Anal. Calc for
C14H17DN4O2: C, 61.09; H, 6.18; N, 20.36%. Found: C,
60.96; H, 6.30; N, 20.22%.
2,2,6,6-Tetradeuterio-4-methylpiperazine (17). A
mixture of N-nitrosopiperazine tetradeuterated 16 (190 mg,
1.4 mmol) in MeOH (5 mL) was stirred at room temperature,
Raney nickel (170 mg) was then added, and the air in the
flask was replaced by hydrogen. The reaction mixture was
vigorous stirred for 6 hours at room temperature. Raney
nickel (170 mg) was then added, and the system was re-
saturated with hydrogen and stirred for 1 hour at room
temperature. The solution was decanted and filtered
through Celite. The solvent was removed in vacuum and
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the residue was the product 17 (60 mg, 40%), which was
used in the next reaction without further purification.
1H NMR (deuteriochloroform): δ 2.00 (s, 1H, NH), 2.35 (s,
3H, CH3-N), 2.36 (m, 4H, -CH2N).
3-[(4-Methyl-2,2,6,6-tetradeuteriopiperazine-1-
yl)methyl]-N2-oxide-4-phenyl-1,2,5-oxadiazole (6-d4). A
mixture of 3 (121 mg, 0.57 mmol), 17 (60 mg, 0.57 mmol),
K2CO3 (80 mg, 0.57 mmol), KI (8 mg, 0.06 mmol) and THF
as solvent was heated at reflux until absence of chloride
(Al2O3, 20% EtOAc in petroleum ether). The solvent was
removed in vacuum and the residue was purified by column
chromatography (Al2O3, CH2Cl2) to yield 40 mg (25%),
colorless oil; IR ν
max
/cm-1: 2917, 2849, 1599, 1575, 1456,
767, 699cm-1; 1H NMR (acetone-d6): δ 2.30 (s, 3H, CH3-N),
2.51 (m, 4H, -CH2N), 3.63 (s, 2H, Ar-CH2N), 7.59 (m, 3H,
phenyl protons), 8.02 (m, 2H, phenyl protons); 13C NMR
(HMQC and HMBC experiments) (acetone-d6): δ 45.90
(CH3-N), 50.00 (Ar-CH2-N), 51.80 (-CD2N), 54.00
(-CH2-N), 113.50 (-C=N+-O-), 126.00 (-C-phenyl), 128.50
(-C-phenyl), 129.50 (-C-phenyl), 131.50 (-C-phenyl),
157.50 (-C=N). Anal. Calc for C14H14D4N4O2: C, 60.43; H,
5.04; N, 20.14%. Found: C, 60.08; H, 5.44; N, 20.02%.
Crystallography
Suitable needles shaped single crystals of 6-d1 were
obtained by slow evaporation from AcOEt. Derivative 6-d1
crystallizes in the monoclinic P21/c space group with a =
10.906(3), b = 14.581(3), c = 10.100(2) Å, β = 114.83(2)°
and Z=4. The structure were solved from 1455 reflections
with I>2s(I) and refined to agreement R1-factors of 0.044.
Most H-atoms were detected in a difference Fourier map.
However, they were positioned stereochemically and refined
with the riding model. The program used to solve and refine
the structure was SHELXS.25 The program used to generate
the ORTEP graphics was ORTEP-II.19
Conclusions
In summary, by using labeling experiments and
adequate analogues, we were able to interpret EI/MS data
to elucidate the fragmentation patterns in mass
spectrometry of 1,2,5-oxadiazole N-oxide derivatives.
Electronic Supplementary Information
Listings of interatomic bond distances, selected angles,
atomic anisotropic displacement parameters, hydrogen
atoms positions and isotropic displacement parameters for
derivative 6-d1 X-ray studies. Available at http://
jbcs.sbq.org.br as a PDF file.
Acknowledgement
We thank the financial support from CONICYT-
Uruguay (Grants 347/95 and 1019/95), Comisión
Honoraria de Lucha contra el Cáncer (Uruguay),
CONICET-Argentina and by FAPESP-Brazil. Part of the
X-ray diffraction experiments were carried out at the
National Diffraction Laboratory (LANADI), La Plata,
Argentina. We also thank Dr. Ana Denicola and Dr. Alvaro
Diaz for critical reading of the manuscript.
References
1. Cerecetto, H.; González, M.; Onetto, S.; Risso, M.; Saenz, P.;
Seoane, G.; Bruno, A.M.; Alarcon, J.; Olea-Azar, C.; López de
Ceráin, A.; Ezpeleta, O.; Monge, A.; Med. Chem. Res. 2001,
10, 328.
2. Cerecetto, H.; Dias, E.; Di Maio, R.; González, M.; Pacce, S.;
Saenz, P.; Seoane, G.; Suescun, L.; Mombrú, A.; Fernández,
G.; Lema, M.; Villalba, J.; J. Agric. Food Chem. 2000, 48,
2995.
3. Monge, A.; López de Ceráin, A.; Ezpeleta, O.; Cerecetto, H.;
Dias, E.; Di Maio, R.; González, M.; Onetto, S.; Risso, M.;
Seoane, G.; Zinola F.; Olea-Azar, C.; Pharmazie 1998, 53, 698.
4. Monge, A.; López de Ceráin, A.; Ezpeleta, O.; Cerecetto, H.;
Dias, E.; Di Maio, R.; González, M.; Onetto, S.; Seoane, G.;
Suescun, L.; Mariezcurrena, R.; Pharmazie 1998, 53, 758.
5. Cerecetto, H.; González, M.; Risso, M.; Seoane, G.; López de
Ceráin, A.; Ezpeleta, O.; Monge, A.; Suescun, L.; Mombrú,
A.; Bruno, A.M.; Arch. Pharm. Pharm. Med. Chem. 2000,
333, 387.
6. Boiani, M.; Cerecetto, H.; González, M.; Risso, M.; Olea-Azar,
C.; Piro, O.E.; Catellano, E.E.; López de Ceráin, A.; Ezpeleta,
O.; Monge-Vega, A.; Eur. J. Med. Chem. 2001, 36, 771.
7. Cerecetto, H.; Di Maio, R.; González, M.; Risso, M.; Saenz, P.;
Seoane, G.; Denicola, A.; Peluffo, G.; Quijano, C.; Olea-Azar,
C.; J. Med. Chem. 1999, 42, 1941.
8. Aguirre, G.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal,
W.; Seoane, G.; Ortega, M.A.; Aldana, I.; Monge, A.; Denicola,
A.; Arch. Pharm. Pharm. Med. Chem. 2002, 335, 15.
9. Fruttero, R.; Ferrarotti, B.; Serafino, A.; Di Stilo, A.; Gasco, A.;
J. Heterocyclic Chem. 1989, 26, 1345; Gasco, A.M.; Fruttero,
R.; Sorba, G.; Gasco, A.; Liebigs Ann. Chem. 1991, 1211;
Gasco, A.; Mortarini, V.; Ruà, G.; Nano, G.M.; Menziani, E.;
J. Heterocyclic Chem. 1972, 9, 577.
10. Hesse, M.; Meier, H.; Zeeh, B.; Spectroscopic Methods in
Organic Chemistry; Thieme: New York, 1997.
11. Suwinski, J.; Svierczek, K.; J. Labelled Compd. Radiopharm.
2002, 45, 795.
12. Vairamani, M.; Rao, K.; Rama, K.; Bhanumathi, N; Sattur,
P.B.; Indian J. Chem. Sect. B 1990, 10, 944.
240 Cerecetto et al. J. Braz. Chem. Soc.
13. McLafferty, F.D.; Turecek, F.; Interpretation of Mass Spectra,
University Science Books: California, 1993.
14. Paudler, W.W.; Chen, T-K.; J. Org. Chem. 1971, 36, 787.
15. Sasaki, T.; Minamoto, K.; Nishikawa, M.; Shima, T.; Tetrahe-
dron 1969, 25, 1021.
16. Hagen, D.F.; Haddad, L.C.; Marhevka, J.S.; Spectrochimica
Acta 1987, 42, 253.
17. Mikaya, A.I.; Trusova, E.A.; Zaikin, V.G.; Volinsky, N.P.;
Karaulova, E.N.; Galpern, G.D.; Org. Mass Spectrom. 1984,
19, 428.
18. As expected, the 1,2,5-oxadiazole heterocycle is planar to
within experimental accuracy, with the oxygen atom of
N-oxide on the ring plane. N-O bond distances in the hetero-
cycle clearly reflect the asymmetry in the bonding structure
imposed by the N-oxide moiety. In fact, the single N1-O2
bond is appreciably longer (1.434(3) Å) than the other, par-
tially double, N2-O2 bond (1.371(3) Å). The phenyl ring
subtends a dihedral angle of 39.20(9)° with the heterocycle.
19. Johnson, C.K.; ORTEP-II. A Fortran Thermal-Ellipsoid Plot
Program. Report ORNL-5138, Oak Ridge National Labora-
tory: Tennessee, USA, 1976.
20. Ravindran, T.; Jeyaraman, R.; Murray, R.W.; Singh, M.; J.
Org. Chem. 1991, 56, 4833.
21. Keefer, L.K.; Fodor, C.H.; J. Am. Chem. Soc. 1970, 92, 5747.
22. Kano, S.; Tamaka, Y.; Sugino, E.; Hibino, S.; Synthesis 1980,
741.
23. Enders, D.; Pieter, R.; Renger, B.; Seebach, D.; Org. Syn.
1978, 58, 113.
24. Aoyagi, Y.; Abe, T.; Ohta, A.; Synthesis 1997, 8, 891.
25. Sheldrick, G.M.; SHELXS-97. Program for Crystal Structure
Resolution, University of Göttingen: Göttingen, Germany,
1997.
Received: January 30, 2003
Published on the web: February 27, 2004
FAPESP helped in meeting the publication costs of this article.
